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Abstract 
Contact dermatitis is a common problem in the 
world of dermatology as well as women’s health, 
where vulvar irritation is a frequent complaint 
among women. It occurs following exposure to 
exogenous irritants (irritant contact dermatitis) or 
allergens (allergic contact dermatitis), and can 
present in acute, subacute, or chronic forms. 
While vulvar pruritus and pain can be seen in a 
number of different conditions, contact dermatitis 
is one of the most common causes encountered 
in clinical practice, and its effects on patient 
quality of life can be dramatic. With a thorough 
history and a complete physical exam, this 
prevalent condition can be diagnosed and 
addressed. Treatment is aimed at identifying 
and eliminating the underlying cause, restoring 
the damaged epithelial barrier, and calming the 
inflammation. Although numerous options are 
available for addressing the itch and pain, the 
only true ”cure” for contact dermatitis is to avoid 
the responsible exposures. 
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Introduction 
Contact dermatitis is a common problem 
in the world of dermatology, manifesting 
as a pruritic or painful rash wherever an 
offending irritant contacts vulnerable 
skin. But this condition is not confined to 
the realm of dermatology; it is also 
common in women’s health, where 
vulvar irritation is a complaint among 
many women. Symptoms can be the 
source of anxiety, fear, and frustration, 
and as such, they may go underreported 
to healthcare providers.1 Although the 
presentation of vulvar contact dermatitis 
shares features with other conditions, a 
high suspicion, combined with proper 
clinical and pathological evaluation, is 
capable of correctly making the 
diagnosis and allowing for appropriate 
management. 
Vulvar Anatomy and Inherent 
Susceptibility 
The vulva is the female external 
genitalia that lie within the anterior 
perineal triangle, spanning from the 
mons pubis anteriorly to the perineal 
body posteriorly and laterally from the 
inguinal crease to the hymenal ring. The 
vulva encompasses the labia majora 
and minora, the clitoral hood, the 
external urethral meatus, the vaginal 
introitus, and the greater (Bartholin’s) 
and lesser (Skene’s) vestibular glands. 
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The area is comprised of two types of 
epithelia, which are separated by Hart’s 
line just medial to the labia minora. 
Lateral to Hart’s line, the labia are 
covered by keratinized epithelium, and 
medial to this line, the mucosal vulvar 
vestibule is lined by non-keratinized 
transitional epithelium. Unlike the rest of 
the external genitalia, the vestibule is 
derived from embryonic endoderm (the 
urogenital sinus) and as such, it 
morphologically resembles the vaginal 
mucosa.2  
Compared to other areas, vulvar skin is 
exposed to many more physiologic 
contact irritants including sweat, vaginal 
secretions, urine, occlusion (by 
underwear, sanitary pads, skin-skin 
contact) and mechanical trauma (from 
sexual activity, scrubbing, etc.). 
Because the vulva is almost always 
covered in some way, the degree of 
occlusion is a unique factor to consider, 
and the effects can be significant. One 
consequence may be increased 
hydration of the skin, as demonstrated 
by measured elevations in 
transepidermal water loss (TEWL).3 
Increased hydration increases the 
friction coefficient of the vulvar skin and 
consequently predisposes to 
mechanical damage.3 TEWL is a 
measure of both hydration and barrier 
function, and increased values suggest 
that vulvar skin is not as effective a 
barrier to water loss as other areas of 
skin.3  
TEWL is also related to permeability, 
which is up to seven times higher in 
vulvar skin than forearm skin.4 Possible 
contributing factors include a higher 
concentration of sweat glands and hair 
follicles, increased cutaneous blood 
flow, and greater hydration. Similar to 
the buccal mucosa of the mouth, 
permeability is particularly elevated in 
the non-keratinized vulvar vestibule 
because the absent stratum corneum 
decreases the barrier function and also 
decreases the distance necessary for an 
exogenous substance to traverse. Cells 
in this area are also more loosely 
arranged, enabling increased 
paracellular movement of penetrants.5 
Thus, vulvar skin is increasingly 
sensitive to topical agents. 
Another unique characteristic of the 
vulvar epithelium is its hormone 
responsiveness, particularly to estrogen. 
The stratum corneum of the labia 
majora gradually thickens with age until 
menopause, at which time circulating 
estrogen levels decline. This leads to 
tissue atrophy and decreased elasticity, 
thus impairing the skin’s ability to act as 
a barrier to external exposures.6 The 
elastic degeneration observed in the 
post-menopausal vulvar dermis is 
comparable to that which is seen with 
years of sun exposure and actinic 
damage in the geriatric population. The 
drop in estrogen additionally increases 
the typically acidic pH of the area and 
decreases production of lipids: two 
factors that normally contribute to the 
skin’s protective function. As a result of 
these changes, the vulvar and vaginal 
tissues become increasingly sensitive to 
injury in the post-menopausal 
population.7 Low estrogen states are 
also observed postpartum and with 
breastfeeding, certain medications (e.g., 
birth control, tamoxifen), and removal of 
the ovaries. Women to whom these 
apply are thus also at increased risk for 
developing vulvar contact dermatitis.  
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Contact Dermatitis 
Contact dermatitis is a common 
diagnosis with reported prevalence rates 
as high as 54% for patients presenting 
to vulvar clinics.8 It occurs after 
exposure to exogenous irritants (irritant 
contact dermatitis) or allergens (allergic 
contact dermatitis), and can present in 
acute, subacute, or chronic forms. 
Severe, acute contact dermatitis can be 
extremely painful, with associated 
erosions and bullous lesions. Chronic 
contact dermatitis may exhibit a milder 
clinical picture, with simple erythema 
and irritation, or it could manifest with 
more pronounced eczematous changes 
including dry, scaly patches and thick, 
lichenified plaques with excoriations, 
fissures, weeping, and possible 
superimposed infection.  
Irritant Contact Dermatitis 
Irritant Contact Dermatitis (ICD) is the 
most common form of contact 
dermatitis,9-12 although its prevalence is 
not entirely known. The condition occurs 
following exposure to substances that 
have direct cytotoxic effects on 
keratinocytes, and as such, does not 
require prior sensitization. These effects 
can include damage to cell membranes, 
denaturation of keratin and other 
proteins, and removal of surface lipids 
and hydrophilic substances.13  
With ICD, burning, stinging, and itching 
are common symptoms, and their 
severity and rapidity of onset are 
determined by the potency of the 
offending agent and the 
duration/chronicity of exposure. A strong 
irritant can cause immediate pain, 
enabling easy recognition of the source, 
while a weaker irritant may bring about 
less obvious changes over an extended 
period, making identification of the 
offender far more difficult. Because the 
vulva is generally well-protected with 
clothing, contact with strong irritants is 
far less common, but patients with 
sensory deficits (e.g. quadriplegics) may 
be unable to recognize when an irritant 
has penetrated their clothing and is 
soaking their skin.  
The damage caused by contact with 
irritants can be additive if intermittent 
exposures are spaced by periods too 
short to allow for recovery of the 
epithelium. Individuals with sensitive 
skin have a lower threshold of 
cumulative damage necessary for the 
manifestation of physical signs and 
symptoms resulting from irritant contact. 
Besides individual variability in skin 
sensitivity, other factors also exist to 
increase risk on an individual basis. 
Obesity results in occlusion by skin-to-
skin contact, which enhances moisture 
production and thus increases friction 
and resultant mechanical damage. The 
additional moisture also allows for 
enhanced permeation of hydrophilic 
agents into the skin. Friction and 
hydrophilia are also increased by urinary 
incontinence, with the added detriment 
of ammonia exposure to the vulvar skin.  
Unlike allergic contact dermatitis, irritant 
reactions are not typically vesicular or 
bullous, although the erosions that can 
occur may give the appearance of 
compromised vesicles. Involved areas 
are often symmetric, with sharp 
demarcations if there is a well-defined 
area of exposure.  As with diaper rash, 
there is often sparing of the inguinal 
creases where the offending agent is 
not as capable of contacting the skin.  
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A variety of substances can cause 
irritant contact dermatitis of the vulva 
(Table 1), including body fluids such as 
urine or stool, hygiene products like 
douches or soaps, or various topical 
medications. Sodium lauryl sulfate 
(SLS) is an anionic detergent and 
surfactant used as a foaming agent in 
many soaps and shampoos, and it has 
been implicated in the induction of ICD 
of the vulva.14 Sodium lauryl sulfate has 
been postulated to contribute to 
hyperalgesia by inducing pro-
inflammatory cytokines.15  
 
Table 1. Vulvar Irritants 
Body Fluids: urine (ammonia), feces (enzymes), vaginal discharge, sweat, semen 
 
Feminine Hygiene Products: douches, feminine wipes, sanitary pads/napkins, panty liners, tampons, 
deodorants, lotions, powders, perfumes, shampoos, soaps  
 
Sexual Support: lubricants, condoms, diaphragms, spermicides, arousal stimulants 
 
Laundry: detergent, bleach, fabric softener 
 
Topical Medicaments: antifungals, anti-itch creams, antibiotics, VagisilR, A+DR ointment, tea tree oil, alcohol-
based creams or gels, cantharidin, 5-fluororacil, ImiquimodR, phenol, podophyllin, bichloroacetic acid, 
trichloroacetic acid 
 
Physical Irritants: tight fitting clothes, nylon, latex, wash cloths, sponges, hot water, excessive washing, 
vigorous drying with towel, hair dryer (on hot) 
Table adapted from Margesson, L.J., Contact dermatitis of the vulva. Dermatol Ther, 2004. 17(1): p. 20-7; 
and Schlosser, B.J., Contact dermatitis of the vulva. Dermatol Clin, 2010. 28(4): p. 697-706. 
 
Allergic Contact Dermatitis 
Unlike ICD, allergic contact dermatitis 
(ACD) is a type IV delayed 
hypersensitivity reaction involving 
antigen-presenting Langerhans cells 
within the epidermis. These dendritic 
cells sample and process antigens at 
the tissue surface and then transport 
them to lymph nodes where they are 
presented to T lymphocytes, inducing T 
cell proliferation and subsequent 
production of inflammatory cytokines. 
Because this immune process takes 
time to progress, physical 
manifestations can take 48 to 72 hours 
to appear following exposure. With such 
delay before symptom development, the 
allergen is often difficult for the patient to 
identify.  
Itching is often a prominent feature of 
ACD, which can be somewhat helpful in 
distinguishing from ICD, in which pain is 
often a primary complaint, though both 
symptoms can be present in either 
disorder. The characteristic appearance 
of ACD includes erythema, edema, and 
possible vesicles or bullae with weeping. 
Because the vulvar skin is thinner, 
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edema may be more prominent than in 
other involved areas. As commonly 
observed with ACD secondary to poison 
ivy exposure, vesicles can assume 
linear or geometric configurations 
aligning with the direction of allergen 
spread by the patient’s fingers or by 
contact with a plant. Round patches of 
dermatitis, for instance, may correspond 
to the circular motion used to rub in a 
cream.  
Chronic ACD may present more as 
scaling plaques with varying degrees of 
erythema, hyperpigmentation, and 
lichenification, possibly complicated by 
comorbid lichen simplex chronicus 
(discussed below). Vesicular responses 
are less common in African Americans 
and others of dark complexion, and 
hyperpigmentation may be so prominent 
as to overpower any erythema,16 so lack 
of these elements should not distract 
from the diagnosis. Besides 
appearance, timing is also important to 
consider, as intermittent or recurrent 
itching is a common presentation 
suggesting episodic exposure to an 
allergen. 
The list of potential allergens is as long 
as, if not longer than, the extensive list 
of known vulvar irritants, making the 
task of identifying the responsible agent 
just as taxing (Table 2). As with irritants, 
allergens can be found in soaps, 
detergents, wipes, and creams. Topical 
medications and remedies are a 
significant source of vulvar ACD, and 
major players include antibiotics (e.g., 
neomycin), topical anesthetics (e.g., 
benzocaine), corticosteroids, and herbal 
extracts.9,17 When a patient reacts to a 
topical medicament, it may not be the 
particular active agent that’s 
responsible, but rather the preservatives 
or vehicle of the medication. Examples 
include parabens in topical antibiotics, 
and the stabilizer, ethylenediamine, 
previously used in antifungal creams in 
the 1970s and 1980s. Added fragrances 
like balsam of Peru and various others 
have also been commonly implicated.18  
Benzocaine is present in many over-the-
counter products including VagisilR and 
several preparations for warts and 
hemorrhoids, meaning patients have 
ample access to this common allergen 
and are frequently using it in the vulvar 
area. Because benzocaine cross-reacts 
with paraaminobenzoic acid, sulfa 
drugs, paraphenylenediamine, and 
aniline dyes, a history of sulfa or hair 
dye allergy can be helpful in suggesting 
possible ACD in vulvar patients using 
this product.19,20  
Because topical corticosteroids are 
commonly used to treat a variety of 
vulvar dermatoses, it’s important to keep 
in mind their potential for inducing 
comorbid ACD. Positive patch test rates 
as high as 10.7% have been reported, 
with many reacting to multiple different 
steroids.21 Corticosteroids have been 
classified into four groups (A-D) based 
on chemical structure and patch test 
results (Table 3), which can help guide 
management in suspected steroid 
allergy.17 High cross-reactivity exists 
within each group as well as between 
Group D2 and Groups A and B. Groups 
C and D1 demonstrate low cross-
reactivity with other groups and are less 
likely to induce ACD.17  
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Table 2. Vulvar Allergens 
Antibiotics: neomycin, bacitracin, sulfonamides, polyline 
 
Antifungals: imidazoles (itraconazole, miconazole, clotrimazole, etc.), nystatin 
 
Antiseptics: chlorhexidine, gentian violet, phenylmercuric salts, mercuric chloride, thimerosal, povidone 
iodine 
 
Anesthetics: esters (benzocaine, tetracaine, procaine), amides (lidocaine, dibucaine, bupivacaine), crotamiton, 
diphenhydramine 
 
Emollients: lanolin, jojoba oil, glycerin, propylene glycol 
 
Corticosteroids: all 
 
Fragrance: Balsam of Peru, cinnamic alcohol, cinnamic aldehyde, hydroxy citronellal, eugenol, isoeugenol 
 
Nail polish: toluene, sulfonamide, formaldehyde resin 
 
Preservatives: stearyl alcohol formaldehyde, formaldehyde releasers (quaternium 15, imidizolidinyl urea, 
diazolidinyl ure), kathon, bronopol 
 
Sanitary wipes: acetyl acetone, fragrance, methacrylates, formaldehyde  
 
Douches: fragrance, oil of eucalyptus, thymol, oxyquinoline, methyl salicylate, phenyl mercuric acetate, 
benzethonium chloride 
 
Metal (jewelry, buttons, etc.): nickel, palladium, gold 
 
Spermicides: quinine hydrochloride, oxyquinoline sulfate nonoxynol, phenylmercuric butyrate, 
phenylmercuric acetate, hexylresorcinol  
 
 
Rubber (diaphragms, condoms, gloves, etc.) : latex, thiurams, mercaptobenzothiazole 
 
Plants (poison ivy/sumac/oak): urushiol 
 
Body fluids: semen, saliva 
Table adapted from Margesson, L.J., Contact dermatitis of the vulva. Dermatol Ther, 2004. 17(1): p. 20-7; 
and Schlosser, B.J., Contact dermatitis of the vulva. Dermatol Clin, 2010. 28(4): p. 697-706. 
Allergies to metals like nickel can also 
present in the vulvar region via contact 
with buttons on clothing, razor blades, or 
finger transmission after handling 
jewelry or other external sources. 
Interestingly, past studies have noted 
that nickel may also be a component of 
toilet papers made from recycled 
paper.9,10 Exposures that are unique to 
the vulva include over-the-counter 
creams intended for vulvar symptoms or 
yeast infections (e.g. VagisilR, nystatin, 
clotrimazole), tampons, sanitary pads, 
moist wipes, and sexual products 
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including various sex toys, lubricants, 
spermicides, and condoms.22-26 Colored 
dyes can be a source of ACD, with 
obvious exposure via underwear and 
more subtle contact occurring through 
colored toilet paper.27  
Histopathologically, ACD and ICD are 
similar and thus pathologic 
discrimination is often not possible. 
Given both are treated similarly, 
confirmation is not clinically necessary.  
Lichen Simplex Chronicus 
Lichen Simplex Chronicus (LSC) is a 
condition that can develop alongside 
pruritic vulvar contact dermatitis as a 
direct result of the patient’s incessant 
scratching. Such repeated trauma 
induces lichenification of the vulvar skin, 
with a thickened appearance, 
accentuation of skin markings, and 
scattered excoriations. Once LSC has 
developed, it causes pruritus even 
without an alternative source, thus 
encouraging further scratching and 
continued worsening of the LSC in what 
is known as the “itch-scratch cycle.” This 
condition may disturb the appearance of 
the primary contact dermatitis, turning 
what may have begun as an 
erythematous, vesicular eruption into a 
series of hyperpigmented plaques. 
 
Table 3. Coopman classification of cross-reactivity in topical corticosteroid 
allergy 
Corticosteroid Group Examples 
  
A hydrocortisone (acetate, succinate, phosphate), cortisone, cortisone acetate, 
fludrocortisone, methylprednisolone (acetate, succinate, phosphate), prednisone, 
prednisolone acetate, tixocortol pivalate 
  
B amcinonide, budesonide, desonide, flunisolide, fluocinolone acetanide, fluocinomide, 
halcinonide, triamcinolone, triamcinolone acetonide 
  
C betamethasone, desoxymethasone, dexamethasone, paramethasone, fluocortolone 
  
D1 beclamethasone dipropionate, betamethasone (valerate, dipropionate), clobethasone 17 
butyrate, clobetasol 17 propyonate 
  
D2 fluticasone, mometasone, prednicarbate, hydrocortisone (17 butyrate, 17 propionate), 
methylprednisolone aceponate 
Table adapted from: Coopman, S., H. Degreef, and A. Dooms-Goossens, Identification of cross-reaction 
patterns in allergic contact dermatitis from topical corticosteroids. Br J Dermatol, 1989. 121(1): p. 27-34. 
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Diagnosis  
Differential Diagnosis 
The clinical presentations of vulvar ICD 
and ACD are similar; additionally their 
clinical features overlap significantly and 
include a number of inflammatory vulvar 
dermatoses. The often eczematous 
appearance of chronic contact 
dermatitis must be distinguished from 
conditions like lichen simplex chronicus, 
seborrheic dermatitis, atopic dermatitis, 
vulvar psoriasis, lichen sclerosus, lichen 
planus, and tinea cruris. More 
concerning possibilities, such as 
squamous cell carcinoma in situ and 
extramammary Paget disease must also 
be considered if the clinical picture is 
consistent and the involved area more 
localized. In cases of acute contact 
dermatitis, where lesions may be more 
vesiculo-erosive, possible diagnoses 
may include disorders like bullous 
pemphigoid, pemphigus vulgaris, 
Hailey-Hailey disease (benign familial 
pemphigus), herpes simplex, 
candidiasis, and erythema multiforme. 
More commonly, contact dermatitis is a 
co-existing condition as noted below. 
Making the Diagnosis 
The possibility of multiple etiologies is 
important to bear in mind, as successful 
treatment may require individual 
identification of all contributing factors. 
For instance, a patient with lichen 
sclerosis may experience an allergic 
contact dermatitis in response to her 
topical steroid ointment or her over-the-
counter antifungal cream for recurrent 
yeast infections. This patient may also 
be an obsessive cleaner who routinely 
scrubs her vulva with an abrasive 
washcloth and a caustic, fragrant soap. 
It is not hard to see how complicated a 
case of vulvar symptoms can become, 
and though cases are not always as 
difficult as this hypothetical example, it’s 
extremely common for the patient to 
come with no idea about what 
exposures (and behaviors) might be 
contributing. In these cases, the astute 
clinician must act much like a detective 
to sift through the assortment of 
possible culprits. 
The patient interview is an essential part 
of the process, and the patient must be 
probed about any and all possible 
exposures to the vulvar area, 
particularly new ones beginning around 
the time of symptom onset. These 
include soaps, laundry detergents, 
sanitary pads, wet wipes, topical 
creams, ointments, powders, dyes in 
underwear or colored toilet paper, 
lubricants, excessively hot water, 
abrasive washrags, and more. The 
investigation must also extend beyond 
the vulva, as potential allergens or 
irritants can be transferred by the 
patient’s fingers from other areas of the 
body, such as the face (makeup) or 
axilla (deodorant), or from the 
surrounding environment. Significant 
others should also be included in the 
questioning, as fragrant body washes or 
other usual suspects can certainly be 
transmitted to the patient during sexual 
activity.  
While interviewing the patient may be 
extremely high yield, sometimes there is 
little information gained, or often the list 
is so broad that further workup is 
needed to narrow the field. Patch testing 
is one commonly used method of 
achieving this goal. The physician, 
usually an allergist, applies a number of 
patches to the patient’s skin, each one 
containing a potential antigen, and then 
monitors for local allergic response. 
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Tests are best read at 48, 72, and 96 
hours. The reaction of the patient’s skin 
informs of any contact allergy for each 
particular substance, and this can be 
helpful in identifying the allergen that 
might be causing the vulvar dermatitis. 
Even so, causation may not be entirely 
straightforward when interpreting patch 
test results in this setting. 
Concentrations of some preservatives, 
for instance, may be lower in actual 
medications than in their respective 
patch. In such a case, real-world 
application of the medicament might not 
exceed the threshold necessary to incite 
ACD, even if the patient had a positive 
patch test to a preservative 
component.28  
If the diagnosis is in question, biopsy 
and /or culture may be indicated. As 
noted, contact dermatitis may be part of 
a multi-factorial process. Secondary 
infection with bacteria, viruses, or fungi 
can occur, and clinical manifestations 
include fissuring, crusting, and pustules.  
Management 
Treatment of vulvar contact dermatitis 
can be quite difficult, involving several 
different medical disciplines including 
dermatology, gynecology, 
psychology/psychiatry (for emotional 
and sexual support), and physical 
therapy (if secondary pelvic floor muscle 
spasms are present).1 The first step in 
treatment—and sometimes the most 
difficult for the patient—is to eliminate all 
potential offending exposures. This 
often involves making dramatic changes 
in the patient’s daily routine, shopping 
habits, and sexual practices, and the 
anxiety produced by this large-scale 
disruption can serve as a significant 
barrier to patient compliance. Such a 
response should be anticipated and 
addressed at the outset of treatment 
and periodically thereafter in order to 
ensure the best chance for 
improvement.  
Vulvar Skin Care  
The goal of vulvar skin care guidelines 
is to decrease vulvar contact with known 
irritants, including chemical products, 
natural moisture, friction, and occlusion. 
Recommendations are broadly 
spanning, including changes in clothing, 
laundry, bathing, hygiene, and birth 
control options. Patients should be 
advised to avoid tight-fitting clothes, 
pantyhose, and synthetic materials (opt 
for pure cotton underwear), and try to 
sleep without underwear to avoid night-
time occlusion. Patients should cease 
use of dryer sheets, fragrant soaps and 
detergents, and dyes.  
When showering or bathing, hot water 
should be avoided, as this can cause 
excess irritation. The vulva should be 
washed gently with one’s hands (no 
washcloths or sponges), using only 
water (no soap), and should be dried 
only by patting with a towel or with a hair 
dryer on its cool setting (no rubbing). 
The patient should not shave the vulva, 
as this can cause irritation and epithelial 
compromise. Trimming/clipping is 
another alternative that is preferred over 
the more direct skin contact with razor 
use.  
Common lubricants, including those 
found in lubricated condoms, should be 
avoided and replaced with more natural 
substitutes, like olive oil, vegetable oil, 
or coconut oil. Vaseline or zinc oxide 
ointment can be used on the vulva to 
protect from exposures such as urine, 
Vulvar contact dermatitis  9 
 
Proceedings in Obstetrics and Gynecology, 2014;4(2):1 
 
blood, or natural moisture. If excessive 
dampness is an issue, powders like 
Gold Bond or Zeasorb can be sprinkled 
in the underwear once or twice a day, 
though fragrant options like baby 
powder, or those containing cornstarch, 
should be avoided.  
Adherence to these guidelines is 
intended to eliminate the offending 
agent (amongst the number of potential 
suspects that are simultaneously 
removed) and result in symptom 
improvement. Following clinical 
resolution of the contact dermatitis, 
individual exposures can be 
reincorporated one-at-a-time, in a 
monthly manner, to enable correlation 
with a particular irritant/allergen if 
symptoms recur.  
Medical Treatment 
The symptoms of contact dermatitis—
burning and itching—are usually the 
main source of patient distress. As such, 
symptom control should be a top priority 
to ensure patient satisfaction and allow 
for the appropriate state of mind with 
which to pursue the lifestyle changes 
necessary for cure.  
To address unremitting pruritus, over-
the-counter antihistamines may be 
useful for some patients.29 A practical 
regimen could include a non-sedating 
antihistamine—like cetirizine (ZyrtecR), 
fexofenadine (AllegraR), or loratadine 
(ClaritinR)—in the morning, and a more 
sedating option—like diphenhydramine 
(BenadrylR) or hydroxyzine (VistarilR, 
AtaraxR)—at night, to support restful 
sleep. Control of itch is not only 
important for patient comfort but may 
also be instrumental in improving the 
dermatitis by decreasing mechanical 
damage from scratching and by 
breaking the itch-scratch cycle that may 
be fueling comorbid LSC. 
For pain, the patient may first try 
acetaminophen or NSAIDs. Topical 
application of petrolatum or zinc oxide, 
while recommended mostly as a skin 
protectant, may also confer a soothing 
effect for some patients. Twice-a-day 
sitz baths and cold compresses can 
mitigate both pain and itch, though cold 
compresses must not be placed in the 
freezer, to avoid frostbite.  
In situations of recalcitrant pain, 
practitioners have turned to pain-
modulating, systemic medications like 
tricyclic antidepressants (e.g. 
amitriptyline, nortriptyline, desipramine) 
and anticonvulsants (e.g. gabapentin, 
pregabalin), which may address the 
neuropathic components of the patient’s 
experience.30,31 To minimize side 
effects, amitriptyline should be started at 
5 mg and gradually increased to 150 
mg. Drowsiness is one of the possible 
side effects of amitriptyline, and if it 
becomes a major issue, desipramine 
(less sedating) can be substituted with a 
target dose of 125-150 mg.31 Selective 
serotonin and norepinephrine reuptake 
inhibitors (SNRIs), such as venlafaxine 
and duloxetine, have also been 
successfully used for vulvar pain, often 
in conjunction with an anticonvulsant.31 
These medications are more commonly 
used for depression, but they can be 
used for pain if the less expensive 
tricyclic class is ineffective. In the US, 
duloxetine has been approved for use in 
neuropathic pain and fibromyalgia.32  
Inflammation should then be targeted, 
most commonly with the use of topical 
corticosteroids. In general, ointments 
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are preferred over creams, as they are 
less irritating, better absorbed, and 
serve additionally as an emollient. To 
begin, twice daily application of a topical 
steroid ointment is essential, and 
potency should be correlated with 
disease severity. Options include low-
potency hydrocortisone 2.5%, mid-
potency triamcinolone acetonide 0.1%, 
and high-potency clobetasol propionate 
0.05% or halobetasol 0.05%. 
Regardless of the steroid chosen, 
frequency of use and potency should be 
weaned as the dermatitis improves, as 
this will avoid unnecessary thinning of 
the skin.  
In severe cases of contact dermatitis 
and vesiculo-erosive disease, systemic 
steroids may be indicated. These can be 
administered as a 14- to 21-day taper of 
oral prednisone, given at a dose of 40-
60 mg daily or 0.5-1 mg/kg/day. 
Alternatively, intramuscular steroids can 
be given as a single dose of 
triamcinolone acetonide 1 mg/kg; while 
this route of administration is less 
burdensome for the patient, it does not 
allow for easy discontinuation if negative 
side effects are encountered. Steroids 
may also be injected intralesionally for 
treatment of particularly thick, stubborn 
plaques or areas of deep inflammation 
resistant to topicals.1 A 1 mL injection of 
triamcinolone acetonide 10 mg/mL can 
be useful for thinning a lesion, and a 
second injection may be repeated. If the 
goal is more anti-inflammatory, 3.3 
mg/mL (triamcinolone acetonide diluted 
in saline) is more appropriate. 
Subsequent injections can be performed 
at 6-week intervals with careful 
monitoring for side effects like atrophy 
or hypopigmentation.1 
Considering the major role that 
corticosteroid therapy plays in treating 
contact dermatitis, it is important to 
anticipate the side effects and plan for 
ways to counteract them. With the 
immunosuppressive effects of both 
systemic and local steroid treatments, 
patients are at increased risk for vulvar 
and vaginal yeast infections. 
Prophylaxis should be considered and 
may include addition of an antifungal to 
topical ointments or use of oral 
fluconazole 150 mg weekly.  
Conclusion 
While vulvar pruritus and pain can be 
seen in a number of different conditions, 
contact dermatitis is one of the most 
common causes encountered in clinical 
practice, and its effects on patient 
quality of life can be dramatic. Due to 
fear and embarrassment, patients often 
opt to endure symptoms, and their 
suffering goes underappreciated. 
However, with thorough interviewing 
and a complete physical exam, this 
prevalent condition can be diagnosed 
and addressed. Treatment is aimed at 
identifying and eliminating the 
underlying cause, restoring the 
damaged epithelial barrier, and calming 
the inflammation with corticosteroids 
and other means. While numerous 
options are available for addressing the 
itch and pain, the only true cure for 
contact dermatitis is to avoid the 
responsible environmental exposures. 
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